There is significant evidence that the pathogenesis of several neurodegenerative diseases, including Parkinson’s disease, Alzheimer’s disease, Friedreich’s ataxia and amyotrophic lateral sclerosis, may involve the generation of reactive oxygen species and mitochondrial dysfunction. Here, we review the evidence for a disturbance of glutathione homeostasis that may either lead to or result from oxidative stress in neurodegenerative disorders. Glutathione is an important intracellular antioxidant that protects against a variety of different antioxidant species. An important role for glutathione was proposed for the pathogenesis of Parkinson’s disease, because a decrease in total glutathione concentrations in the substantia nigra has been observed in preclinical stages, at a time at which other biochemical changes are not yet detectable. Because glutathione does not cross the blood‐brain barrier other treatment options to increase brain concentrations of glutathione including glutathione analogs, mimetics or precursors are discussed.

/pdf/glutathione-oxidative-stress-and-neurodegeneration-3snwv71o78.pdf

Glutathione, oxidative stress and neurodegeneration.

Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death.

Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice.

Amyotrophic lateral sclerosis (ALS) is a genetically diverse disease. At least 15 ALS-associated gene loci have so far been identified, and the causative gene is known in approximately 30% of familial ALS cases. Less is known about the factors underlying the sporadic form of the disease. The molecular mechanisms of motor neuron degeneration are best understood in the subtype of disease caused by mutations in superoxide dismutase 1, with a current consensus that motor neuron injury is caused by a complex interplay between multiple pathogenic processes. A key recent finding is that mutated TAR DNA-binding protein 43 is a major constituent of the ubiquitinated protein inclusions in ALS, providing a possible link between the genetic mutation and the cellular pathology. New insights have also indicated the importance of dysregulated glial cell-motor neuron crosstalk, and have highlighted the vulnerability of the distal axonal compartment early in the disease course. In addition, recent studies have suggested that disordered RNA processing is likely to represent a major contributing factor to motor neuron disease. Ongoing research on the cellular pathways highlighted in this Review is predicted to open the door to new therapeutic interventions to slow disease progression in ALS.

Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis

J.D. Mitchell

Papers

Evidence for DNA damage in amyotrophic lateral sclerosis.

Studies on cellular free radical protection mechanisms in the anterior horn from patients with amyotrophic lateral sclerosis.

Cu/Zn superoxide dismutase free radicals, and motoneuron disease

Alteration of superoxide dismutase activity in the anterior horn in motoneuron disease patients

Serial studies of free radical and antioxidant activity in motor neurone disease and the effect of selegiline.